BackHepion Pharmaceuticals Overview

Hepion Pharmaceuticals Operating Income

Operating Income for HEPA.

Quarterly Operating Income

$-798509.00
↓ 37.65% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-3681605.00
↓ 76.16% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin